| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V88158 | Antitumor agent-172 | 3027905-74-1 | Antitumor agent-172 (Compound 28) is an inhibitor of β-catenin/BCL9 interaction with IC50 of 3.92 μM. |
|
V51021 | Miclxin (DS-37262926) | 2494198-61-5 | Miclxin (DS37262926) is a potent inhibitor of mutant β-catenin, involved in Wnt signaling. |
|
V140517 | Murayaquinone | 100843-91-2 | Murayaquinone is a β-catenin/Tcf4 complex inhibitor with an IC50 of 2.4 μM. |
|
V144460 | S118 | 2677041-36-8 | S118 is an orally effective sphingosine-1-phosphate receptor 2 (S1P2 receptor) inhibitor. |
|
V145027 | SLD1121 | 2759011-75-9 | SLD1121 is a Wnt/β-catenin signaling pathway agonist that enhances Wnt signaling by targeting LRP6 (Kd: 4.52-7.49 nM). |
|
V145088 | SNX3-IN-1 | 2344793-72-0 | SNX3-IN-1 is a sorting linker protein 3 (SNX3) inhibitor. |
|
V145457 | Surbisiran | 2897552-25-7 | Surbisiran is a siRNA with anti-tumor activity that inhibits the synthesis of β-catenin. |
|
V145458 | Surbisiran sodium | Surbisiran sodium is a siRNA with antitumor activity. | |
|
V145952 | TFAP4/Wnt/β-catenin-IN-1 | 3115114-11-6 | TFAP4/Wnt/β-catenin-IN-1 is an orally effective TFAP4/Wnt/β-catenin inhibitor. |
|
V51001 | WAY-332060 | 1015858-82-8 | beta-catenin modulator |
|
V147129 | Wnt/β-catenin activator 1 | Wnt/β-catenin activator 1 is an orally effective activator of the Wnt/β-catenin signaling pathway that can arrest the cell cycle in the G1 phase, inhibit early adipocyte proliferation, and inhibit adipogenesis in 3T3-L1 cells with an IC50 of 330 nM. | |
|
V147186 | XIAP-CASP7 PPI-IN-1 | XIAP-CASP7 PPI-IN-1 is a reversible XIAP:CASP7 inhibitor that specifically disrupts the interaction between XIAP and CASP7. | |
|
V147395 | Zolucatetide | 3044032-95-0 | Zolucatetide is a potent β-catenin inhibitor with an IC50 < 50 nM. |
|
V69185 | ZW4864 | 2632259-93-7 | ZW4864 is an orally bioactive and selective inhibitor of β catenin/B-Cell lymphoma 9 protein-protein interaction (β catenin/BCL9 PPI). |
|
V51022 | β-catenin-IN-37 | 1783856-40-5 | β-catenin-IN-37 is a selective amplification of β-catenin/T-cell factor protein interaction (β-catenin/Tcf PPI). |
|
V69184 | β-catenin-IN-6 | 1039731-99-1 | β-catenin-IN-6 is a β-catenin inhibitor that targets the canonical wingless-related integration site signaling pathway. |
|
V85390 | β-catenin/BCL9 PPI-IN-1 |